Principal Stratification in Causal Inference
暂无分享,去创建一个
[1] S G Baker,et al. Regression analysis of grouped survival data: informative censoring and double sampling. , 1993, Biometrics.
[2] P Flandre,et al. Estimating the proportion of treatment effect explained by a surrogate marker. , 1999, Statistics in Medicine.
[3] J. Heckman. Dummy Endogenous Variables in a Simultaneous Equation System , 1977 .
[4] Geert Molenberghs,et al. Causal Inference in a Placebo-Controlled Clinical Trial with Binary Outcome and Ordered Compliance , 1996 .
[5] R. Prentice. Surrogate endpoints in clinical trials: definition and operational criteria. , 1989, Statistics in medicine.
[6] D. Rubin,et al. Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes , 1999 .
[7] Anna C. Balazs,et al. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. , 1980, The New England journal of medicine.
[8] J. Robins,et al. Adjusting for differential rates of prophylaxis therapy for PCP in high- versus low-dose AZT treatment arms in an AIDS randomized trial , 1994 .
[9] Glenn Shafer,et al. Comments on "Causal Inference without Counterfactuals" by A.P. Dawid , 1999 .
[10] Donald B. Rubin,et al. Addressing an Idiosyncrasy in Estimating Survival Curves Using Double Sampling in the Presence of Self‐Selected Right Censoring , 2001 .
[11] D. Rubin. Assignment to Treatment Group on the Basis of a Covariate , 1976 .
[12] G. Molenberghs,et al. Criteria for the validation of surrogate endpoints in randomized experiments. , 1998, Biometrics.
[13] Joshua D. Angrist,et al. Identification of Causal Effects Using Instrumental Variables , 1993 .
[14] J. Robins. A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect , 1986 .
[15] D. Rubin. Estimating causal effects of treatments in randomized and nonrandomized studies. , 1974 .
[16] Donald B. Rubin,et al. Bayesian Inference for Causal Effects: The Role of Randomization , 1978 .
[17] D B Rubin,et al. More powerful randomization-based p-values in double-blind trials with non-compliance. , 1998, Statistics in medicine.
[18] T. Speed,et al. On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Section 9 , 1990 .
[19] D. DeMets,et al. Surrogate End Points in Clinical Trials: Are We Being Misled? , 1996, Annals of Internal Medicine.
[20] D. Rubin,et al. Assessing the effect of an influenza vaccine in an encouragement design. , 2000, Biostatistics.
[21] P. Holland. Statistics and Causal Inference , 1985 .
[22] S G Baker,et al. The paired availability design: a proposal for evaluating epidural analgesia during labor. , 1994, Statistics in medicine.
[23] J. Pearl,et al. Bounds on Treatment Effects from Studies with Imperfect Compliance , 1997 .
[24] D. Rubin,et al. Assessing Sensitivity to an Unobserved Binary Covariate in an Observational Study with Binary Outcome , 1983 .
[25] R J Carroll,et al. On meta-analytic assessment of surrogate outcomes. , 2000, Biostatistics.
[26] W. G. Cochran. Analysis of covariance: Its nature and uses. , 1957 .
[27] P. Rosenbaum. The Consequences of Adjustment for a Concomitant Variable that Has Been Affected by the Treatment , 1984 .
[28] V De Gruttola,et al. Estimating the proportion of treatment effect explained by a surrogate marker. , 1997, Statistics in medicine.
[29] S. Vansteelandt,et al. Discussion of 'Clustered encouragement designs with individual noncompliance: Bayesian inference with randomization, and application to advance directive forms' by Frangakis, Rubin and Zhou. , 2002, Biostatistics.
[30] D. Rubin. Comment on "Causal inference without counterfactuals," by Dawid AP , 2000 .
[31] J M Robins,et al. Correction for non-compliance in equivalence trials. , 1998, Statistics in medicine.
[32] A. P. Dawid,et al. Causal inference without counterfactuals (with Discussion) , 2000 .
[33] James J. Heckman,et al. Identification of Causal Effects Using Instrumental Variables: Comment , 1996 .
[34] G. Molenberghs,et al. The validation of surrogate endpoints in meta-analyses of randomized experiments. , 2000, Biostatistics.
[35] C. Manski. Nonparametric Bounds on Treatment Effects , 1989 .
[36] A. Dawid. Causal Inference without Counterfactuals , 2000 .
[37] D. Rubin,et al. School Choice in NY City: A Bayesian Analysis of an Imperfect Randomized Experiment , 2001 .
[38] D. Rubin,et al. Bayesian inference for causal effects in randomized experiments with noncompliance , 1997 .
[39] S. Rössner,et al. Coronary Drug Project Research Group. , 1978, Atherosclerosis.
[40] J. Robins,et al. Identifiability and Exchangeability for Direct and Indirect Effects , 1992, Epidemiology.
[41] B. Graubard,et al. Statistical validation of intermediate endpoints for chronic diseases. , 1992, Statistics in medicine.
[42] S. Zeger,et al. On estimating efficacy from clinical trials. , 1991, Statistics in medicine.
[43] A. Goldberger. STRUCTURAL EQUATION METHODS IN THE SOCIAL SCIENCES , 1972 .
[44] J. Robins,et al. Adjusting for Nonignorable Drop-Out Using Semiparametric Nonresponse Models , 1999 .
[45] D. Rubin. ASSIGNMENT TO TREATMENT GROUP ON THE BASIS OF A COVARIATE , 1976 .
[46] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .
[47] J. Thorp. Epidural analgesia during labor. , 1999, Clinical obstetrics and gynecology.
[48] D. Rubin. [On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Section 9.] Comment: Neyman (1923) and Causal Inference in Experiments and Observational Studies , 1990 .